Spine biologics market to grow to 2026 — Who are the key market players?

Written by Megan Wood | November 02, 2016 | Print  |

A Future Market Insights report found the spine biologics market will grow between 2016 and 2026, according to medGadget.

Here are five observations:

 

1. Technology advancements and demand for minimally invasive surgery will spur the spine biologics market growth.

 

2. Additionally, the aging population, rising prevalence of disease and increasing government funding will also boost the market.

 

3. North America currently possesses the largest market share, but the Asia-Pacific region will likely see the most growth due to high populations.

 

4. The costliness of procedures as well as the availability of substitute products will serve as barriers to market growth.

 

5. Alphatec Spine, Medtronic, Zimmer Biomet, Globus Medical, Exactech, RTI Biologics, Small Bone Innovations, Stryker, Amedica, K2M, NuVasive, Precision Spine and TranS1 represent leaders in the market.

 

More articles on devices:
FDA clears Onkos Surgical's ELEOS Limb Salvage System: 5 things to know
Positive 2-year results for Zimmer Biomet's Aspen MIS Fusion System: 3 insights
Robotics & navigation technology grab spotlight at NASS meeting

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months